Valeur202020212022202320242025TTMFrais de vente, généraux et administratifs———————Recherche et développement———————Résultat d'exploitation———————Total des produits hors exploitation———————Charges d'intérêts, nettes des intérêts capitalisés———————Résultat hors exploitation, hors charges d'intérêts———————Revenus/dépenses exceptionnels———————Résultat avant impôts———————Part des actionnaires dans le résultat———————Impôts———————Intérêts ne donnant pas le contrôle / intérêts minoritaires———————Autres produits/charges après impôts———————Résultat net avant activités abandonnées———————Activités abandonnées———————Résultat net———————Ajustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires———————Bénéfice par action de base (BPA de base)———————Bénéfice par action dilué (BPA dilué)———————Nombre moyen d'actions de base en circulation———————Nombre d'actions en circulation après dilution———————EBITDA———————EBIT———————Coût des ventes———————Autres coûts des ventes———————Amortissements (flux de trésorerie)———————
Sanofi - American Depositary Shares
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in the Forbes Global 2000 was 89.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur.